Communiqués Dancann Pharma A/S

Actions

DANCAN

DK0061410487

Cours en clôture NORDIC GROWTH MARKET Autres places de cotation 00:00:00 05/07/2024			Varia. 5j.	Varia. 1 janv.
0,0344 ^DKK	-7,53%		-16,10%	+14,67%

18/06	DanCann Pharma A/S fournit des prévisions de recettes pour l'année 2024	CI
01/06	DanCann Pharma A/S présente ses résultats pour le premier trimestre clos le 31 mars 2024	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

DanCann Pharma: DanCann Pharma A/S announces last day for trading in temporary shares	03/07	PU
DanCann Pharma A/S announces last day for trading in temporary shares	03/07	AQ
DanCann Pharma: DanCann Pharma A/S announces outcome of the Rights Issue	27/06	PU
DanCann Pharma A/S announces outcome of the Rights Issue	27/06	AQ
DanCann Pharma: DanCann Pharma A/S: Last day of subscription of shares in the ongoing Rights Issue is 20 June 2024 on Nordnet Bank and Avanza Bank	19/06	PU
DanCann Pharma: DanCann Pharma A/S: Solid growth in the Rx portfolio	19/06	PU
DanCann Pharma A/S: Last day of subscription of shares in the ongoing Rights Issue is 20 June 2024 on Nordnet Bank and Avanza Bank	19/06	AQ
DanCann Pharma A/S: Solid growth in the Rx portfolio	18/06	AQ
DanCann Pharma: DanCann Pharma A/S: Germany trends – prescriptions for medicinal cannabis positively influenced by new legalization	14/06	PU
DanCann Pharma A/S: Germany trends - prescriptions for medicinal cannabis positively influenced by new legalization	14/06	AQ
DanCann Pharma: DanCann Pharma A/S: Submits applications for FLS03 and FLS04 to expand portfolio	12/06	PU
DanCann Pharma A/S: Submits applications for FLS03 and FLS04 to expand portfolio	12/06	AQ
DanCann Pharma A/S: The subscription period of DanCann Pharma's Rights Issue begins today	11/06	AQ
DanCann Pharma A/S: Publishes Q1-2024 Report	01/06	AQ
DanCann Pharma A/S: Minutes OF ANNUAL GENERAL MEETING	30/05	AQ
DanCann Pharma A/S: The Board of Directors has resolved on a partially (48.88 percent) secured Rights Issue of approximately DKK 18.33 million and publishes memorandum	24/05	AQ
DanCann Pharma A/S: Capital reduction completed	16/05	AQ
NOTICE OF ANNUAL GENERAL MEETING 2024 IN DANCANN PHARMA A/S	15/05	AQ
DanCann Pharma A/S Publishes Its Annual Report for 2023: A Year of Strategic Review and Future Focus on Capital Efficiency and Profitability	15/05	AQ
DanCann Pharma A/S: Updated time plan and material terms of the rights issue	15/05	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Dancann Pharma A/S

Actions

DANCAN

DK0061410487

Communiqués

Filtres